Add-on activity
This activity includes patient counseling videos.
Program Description
Treatments for beta thalassemia include regular blood transfusions, iron chelation therapy, and supportive care practices. However, lifelong blood transfusions are associated with several serious risks and adverse effects that can negatively affect patients’ quality of life. As such, nonadherence to therapy remains an important barrier that pharmacists on the multidisciplinary care team must work to address. This panel discussion will focus on tactics pharmacists can implement in practice to improve patient adherence to therapy, manage patient care and transitions as they age, and communicate with patients about efficacy and safety of emerging therapies.
Target audience: Health-system and specialty pharmacists
Type of activity: Application
Release date: July 29, 2022
Expiration date: July 29, 2023
Time to complete activity: 1.75 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify therapies that constitute current standards of care and current clinical best practices for treating beta thalassemia
- Explain the role of emerging therapies entering the market in disease management and their paradigm-changing potential
- Illustrate the importance of specialty pharmacists in managing beta thalassemia and medication adverse events
Leslie Ward, PharmD, BCPS, BCOP
Moderator
Clinical Pharmacist, Benign Hematology
University of Virginia Health
Charlottesville, Virginia
Jeanne Boudreaux, MD
Associate Professor of Pediatrics
Director of the Comprehensive Thalassemia Program
Clinical Director of General Hematology
Aflac Cancer & Blood Disorders Center/Emory University,
Children's Healthcare of Atlanta
Justin Arnall, PharmD, BCOP
Clinical Coordinator, Hematology
Specialty Pharmacy Service, Atrium Health
Charlotte, North Carolina
Kathryn E. Dane, PharmD, BCPS
Clinical Pharmacist, Benign Hematology and Cardiology
Co-director, Hemostatic and Antithrombotic Stewardship Program
The Johns Hopkins Hospital
Baltimore, Maryland
Jeannette Y. Wick, RPh, MBA, FASB
Medical Writer for Panel Discussion and Patient Counseling Videos
Director
Office of Pharmacy Professional Development
University of Connecticut School of Pharmacy
Storrs, Connecticut
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.75 contact hours (0.175 CEU) under the ACPE universal activity number 0290-0000-22-343-H01-P. The activity is available for CE credit through July 29, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Jeanne Boudreaux, MD, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: CDC, Evidera
Consultant (advisory board): Cooley’s Anemia Foundation, ApoPharma, Celgene/Acceleron/Bristol Myers Squibb, bluebird bio
Other (steering committee): bluebird bio
Other (data and safety monitoring board): ApoPharma
Justin Arnall, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: (Advisory Board) CTI BioPharma
Speaker's Bureau: Novo Nordisk, Bleeding Disorders
The following contributors have no relevant financial relationships with commercial interests to disclose:
Moderator
Leslie Ward, PharmD, BCPS, BCOP
Faculty
Kathryn E. Dane, PharmD, BCPS
Medical Writer for Panel Discussion and Animation Videos
Jeannette Y. Wick, RPh, MBA, FASB
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms